Aberrant expression of double-stranded RNA-dependent protein kinase in hepatocytes of chronic hepatitis and differentiated hepatocellular carcinoma - PubMed (original) (raw)
. 1998 Oct 1;58(19):4434-8.
Affiliations
- PMID: 9766675
Aberrant expression of double-stranded RNA-dependent protein kinase in hepatocytes of chronic hepatitis and differentiated hepatocellular carcinoma
A Shimada et al. Cancer Res. 1998.
Abstract
We immunohistochemically analyzed the expression of double-stranded RNA-dependent protein kinase (PKR) using a monoclonal antibody, 71/10. Test samples included 64 human liver biopsies and 25 liver sections of rats inoculated with diethylnitrosamine. The PKR signals in human fatty livers and normal rat livers were minimum. Scoring signal intensity from 0-4, the average scores of chronic active (14 cases) and chronic persistent (6 cases) hepatitis associated with hepatitis virus C (HCV) were 2.8 and 2.0, respectively (P = 0.038). The stained cells were significantly more abundant in the periportal than centrilobular regions for both chronic active and persistent hepatitis (P < 0.001 each). The average score of liver cirrhosis associated with HCV was 1.9. Those scores of well-, moderately, and poorly differentiated hepatocellular carcinomas associated with HCV were 3.4, 2.1, and 0.3, respectively (P < 0.001 for each pair). Those scores of well- and poorly differentiated carcinomas associated with hepatitis virus B were 2.3 and 0.0, respectively (P < 0.001). The average score of rat carcinomas induced by diethylnitrosamine was 1.9. Morphologically, nuclei of the vast majority of PKR-positive cells looked not apoptotic. The ratio of PKR-positive cells to apoptotic cells by terminal transferase-mediated dUTP nick end labeling method was approximately 20 in hepatitis, and over 100 in well-differentiated carcinoma.
Similar articles
- Reduction of double-stranded RNA-activated protein kinase in hepatocellular carcinoma associated with hepatitis B virus.
Chen GG, Lai PB, Ho RL, Chan PK, Xu H, Wong J, Lau WY. Chen GG, et al. J Med Virol. 2004 Jun;73(2):187-94. doi: 10.1002/jmv.20074. J Med Virol. 2004. PMID: 15122791 - Protein kinase R is increased and is functional in hepatitis C virus-related hepatocellular carcinoma.
Hiasa Y, Kamegaya Y, Nuriya H, Onji M, Kohara M, Schmidt EV, Chung RT. Hiasa Y, et al. Am J Gastroenterol. 2003 Nov;98(11):2528-34. doi: 10.1111/j.1572-0241.2003.08663.x. Am J Gastroenterol. 2003. PMID: 14638359 - Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma.
El-Bassiouni A, Nosseir M, Zoheiry M, El-Ahwany E, Ghali A, El-Bassiouni N. El-Bassiouni A, et al. APMIS. 2006 Jun;114(6):420-7. doi: 10.1111/j.1600-0463.2006.apm_323.x. APMIS. 2006. PMID: 16856963 - [The natural course of hepatitis B and hepatitis C virus infection].
Schwabe RF, Stremmel W. Schwabe RF, et al. Praxis (Bern 1994). 1998 Oct 14;87(42):1403-7. Praxis (Bern 1994). 1998. PMID: 9824947 Review. German. - Alteration of protein glycosylation in liver diseases.
Blomme B, Van Steenkiste C, Callewaert N, Van Vlierberghe H. Blomme B, et al. J Hepatol. 2009 Mar;50(3):592-603. doi: 10.1016/j.jhep.2008.12.010. Epub 2008 Dec 27. J Hepatol. 2009. PMID: 19157620 Review.
Cited by
- PKR associates with 4.1R to promote anchorage-independent growth of hepatocellular carcinoma and lead to poor prognosis.
Okujima Y, Watanabe T, Ito T, Inoue Y, Kasai Y, Imai Y, Nakamura Y, Koizumi M, Yoshida O, Tokumoto Y, Hirooka M, Abe M, Kawakami R, Saitou T, Imamura T, Murakami Y, Hiasa Y. Okujima Y, et al. Sci Rep. 2024 Nov 13;14(1):27768. doi: 10.1038/s41598-024-75142-5. Sci Rep. 2024. PMID: 39532917 Free PMC article. - Eukaryotic translation initiation factor 2α kinase 2 in pancreatic cancer: An approach towards managing clinical prognosis and molecular immunological characterization.
Du HX, Wang H, Ma XP, Chen H, Dai AB, Zhu KX. Du HX, et al. Oncol Lett. 2023 Sep 21;26(5):478. doi: 10.3892/ol.2023.14066. eCollection 2023 Nov. Oncol Lett. 2023. PMID: 37818134 Free PMC article. - Cellular Stress: Modulator of Regulated Cell Death.
Lamichhane PP, Samir P. Lamichhane PP, et al. Biology (Basel). 2023 Aug 25;12(9):1172. doi: 10.3390/biology12091172. Biology (Basel). 2023. PMID: 37759572 Free PMC article. Review. - UBR5 promotes tumor immune evasion through enhancing IFN-γ-induced PDL1 transcription in triple negative breast cancer.
Wu B, Song M, Dong Q, Xiang G, Li J, Ma X, Wei F. Wu B, et al. Theranostics. 2022 Jul 4;12(11):5086-5102. doi: 10.7150/thno.74989. eCollection 2022. Theranostics. 2022. PMID: 35836797 Free PMC article. - Protein kinase RNA-activated controls mitotic progression and determines paclitaxel chemosensitivity through B-cell lymphoma 2 in ovarian cancer.
Yin L, Zeng Y, Zeng R, Chen Y, Wang TL, Rodabaugh KJ, Yu F, Natarajan A, Karpf AR, Dong J. Yin L, et al. Oncogene. 2021 Dec;40(50):6772-6785. doi: 10.1038/s41388-021-02117-5. Epub 2021 Nov 19. Oncogene. 2021. PMID: 34799660 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical